I’m a big Formula 1 fan and thoroughly enjoyed the TV coverage of the Las Vegas Grand Prix over the weekend.

The event hit a bit of a snag in the opening practice session, but overcame the problem within a few hours to continue as previously organized.

The amount of planning and preparation work that went into running a Grand Prix along the Strip and around some of the famous sites has been incredible. (For instance, I was in Vegas in May and the road was being resurfaced then specifically for the race).

The reason I’m mentioning it is that worldwide revenues for Formula 1 were approximately 2.5 billion dollars in 2022.

While 2022 revenues for the global pharma industry were around 1.4 trillion dollars.

Which makes me wonder why our industry still has a major issue with patient recruitment, when a much smaller industry can successfully deliver something so complicated straight off the bat.